THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 47 filers reported holding THESEUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,169 | -70.1% | 10,100 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $90,884 | +24.8% | 9,741 | +18.8% | 0.00% | – |
| Q1 2023 | $72,825 | +82.0% | 8,201 | +2.0% | 0.00% | – |
| Q4 2022 | $40,024 | -14.8% | 8,037 | -0.4% | 0.00% | – |
| Q3 2022 | $47,000 | +6.8% | 8,066 | +1.4% | 0.00% | – |
| Q2 2022 | $44,000 | -33.3% | 7,952 | +39.2% | 0.00% | – |
| Q1 2022 | $66,000 | -15.4% | 5,714 | -6.6% | 0.00% | – |
| Q4 2021 | $78,000 | – | 6,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 959,275 | $5,305,000 | 13.37% |
| Foresite Capital Management V, LLC | 3,335,346 | $18,444,000 | 12.88% |
| Lynx1 Capital Management LP | 504,862 | $2,792,000 | 2.38% |
| Orbimed Advisors | 17,041,668 | $94,240,000 | 1.71% |
| Omega Fund Management, LLC | 711,479 | $3,934,000 | 1.26% |
| Nextech Invest Ltd. | 611,310 | $3,381,000 | 1.14% |
| Boxer Capital, LLC | 892,057 | $4,933,000 | 0.31% |
| DAFNA Capital Management LLC | 81,899 | $453,000 | 0.12% |
| Opaleye Management Inc. | 32,300 | $179,000 | 0.08% |
| Rock Springs Capital Management LP | 437,329 | $2,418,000 | 0.07% |